NDC 50480-052-50 - CMPK2
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50480-052
- Requested NDC
- 50480-052-50
- Package NDCs from labels
- 50480-052-50
- Manufacturer
- Radix Laboratories, Inc.
- Effective date
- 2014-03-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CMPK2 | Radix Laboratories, Inc. | 2014-03-24 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50480-052-50 | CMPK2 | 12 in 1 CARTON | LIQUID | 12 | 3 | |
| 50480-052-50 | CMPK2 | 500 mL in 1 BOTTLE, PLASTIC | LIQUID | 500 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CALCIUM BOROGLUCONATE | ACTIVE INGREDIENT | 6915G2PQI0 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | LX22YL083G | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| MAGNESIUM CHLORIDE | ACTIVE INGREDIENT | 02F3473H9O | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| SODIUM HYPOPHOSPHITE | ACTIVE INGREDIENT | 8TU1537O43 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| ANHYDROUS DEXTROSE | ACTIVE MOIETY | 5SL0G7R0OK | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| HYPOPHOSPHITE ION | ACTIVE MOIETY | 238U65NZ04 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | CMPK2 LIQUID [RADIX LABORATORIES, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | ace1eb11-b925-405a-b772-58c60b3ca7d4 | 2026-09-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | LX22YL083G |
| Nerve Guard Nerve Relief | LIDOCAINE HYDROCHLORIDE, MENTHOL,MAGNESIUM CHLORIDE | Micelle Laboratories, Incorporated | 6b78f40f-2a7f-4c49-96af-1a95acbf430f | 2026-09-04 | Warnings | 02F3473H9O |
| BMNP Kali Mur | KALIUM MURIATICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a546950-3f03-7abf-e063-6294a90a1968 | 2026-08-31 | Warnings | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | b8b77421-d687-45aa-82f6-d49bce644c10 | 2026-08-31 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | 2c407aaf-5d95-49ff-a5db-f1d7b5190334 | 2026-08-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Electrolyte Plus | KALI MURIATICUM, L-ARGININE, L-CARNITINE, L-LEUCINE, L-ORNITHINE, L-VALINE, MAGNESIA MURIATICA, ASCORBICUM ACIDUM, BORAX, CHROMIUM OXYDATUM, FERRUM MURIATICUM, KALI CARBONICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, NATRUM MURIATICUM, ZINCUM GLUCONICUM, CUPRUM METALLICUM, KALI PHOSPHORICUM, NICCOLUM METALLICUM, SELENIUM METALLICUM, VANADIUM METALLICUM, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, MANGANUM CARBONICUM | Deseret Biologicals, Inc. | e3564733-8b88-4753-9077-9d74004d8ec9 | 2026-08-25 | Warnings | 02F3473H9O 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Cardinal Health 107, LLC | ea55ded1-e076-43de-ad3c-c75e7d0a4ebc | 2026-08-24 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | Cardinal Health 107, LLC | fea3ae21-3395-437e-b773-b180e1c98801 | 2026-08-24 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Coupler LLC | 598f61d7-a665-5d02-e063-6394a90a8905 | 2026-08-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Bio Combination 28 | SCHUESSLER SALTS | LDD Bioscience Private Limited | 597caf33-5107-9dec-e063-6294a90a5fcd | 2026-08-20 | Warnings | 660YQ98I10 |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | df18a603-ca12-4b26-83b5-9dd07b6453ab | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 02F3473H9O LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 02F3473H9O LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-08-18 | Warnings, Adverse reactions | 02F3473H9O LX22YL083G |
| Potassium Chloride | POTASSIUM CHLORIDE | Preferred Pharmaceuticals Inc. | 3f19ed0e-6c73-482c-94d6-d3205318fd6f | 2026-08-17 | Warnings, Adverse reactions | 660YQ98I10 |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 660YQ98I10 |
| BM BM165 DROPS | ANGELICA ATRO, BALSAM PER, BARIUM MUR, GRINDELIA, KALI BICH, KALI IOD, KALI MUR, SILPHIUM LAC | BM Private Limited | 590301da-8f93-3b1e-e063-6394a90a1e72 | 2026-08-14 | Warnings | 660YQ98I10 |
| Hepatic-Tone | CARDUUS MARIANUS, CEANOTHUS AMERICANUS, CHELIDONIUM MAJUS, CHIONANTHUS VIRGINICA, CITRICUM ACIDUM, CYSTEINUM, HEPAR SUIS, LEPTANDRA VIRGINICA, MAGNESIA MURIATICA, NATRUM SULPHURICUM, NUX VOMICA, PHOSPHORUS, QUASSIA (AMARA), TARAXACUM OFFICINALE | Energetix Corporation | d5f61f13-7e9f-4e46-8ad8-0336f36288df | 2026-08-11 | Warnings | 02F3473H9O |
| Potassium Chloride | POTASSIUM CHLORIDE | Amneal Pharmaceuticals LLC | f9965f73-e189-423f-bd10-c4a0ed12b485 | 2026-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.